MicroRNAs in cholangiopathies: Potential diagnostic and therapeutic tools.

Clin Res Hepatol Gastroenterol

Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastián, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Instituto de Salud Carlos III), Madrid, Spain; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain. Electronic address:

Published: February 2016

Cholangiopathies are the group of diseases targeting the bile duct epithelial cells (i.e. cholangiocytes). These disorders arise from different etiologies and represent a current diagnostic, prognostic and therapeutic challenge. Different molecular mechanisms participate in the development and progression of each type of biliary disease. However, microRNA deregulation is a common central event occurring in all of them that plays a key role in their pathogenesis. MicroRNAs are highly stable small non-coding RNAs present in cells, extracellular microvesicles and biofluids, representing valuable diagnostic tools and potential targets for therapy. In the following sections, the most novel and significant discoveries in this field are summarized and their potential clinical value is highlighted.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinre.2015.10.001DOI Listing

Publication Analysis

Top Keywords

micrornas cholangiopathies
4
cholangiopathies potential
4
potential diagnostic
4
diagnostic therapeutic
4
therapeutic tools
4
tools cholangiopathies
4
cholangiopathies group
4
group diseases
4
diseases targeting
4
targeting bile
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!